Pfizer

Pfizer Oncology – Let’s Outdo Cancer

Pfizer has been partnering with Komen on a local and national level since 2015. Pfizer supports Komen across multiple advocacy initiatives including the Komen Center for Public Policy, Clinical Trial Diversity, the MBC Impact Series, and many Komen Race for the Cure and More than Pink Walks. These initiatives reflect how Pfizer is able to combine Joy, Courage, Equity, and Excellence to accelerate breakthroughs to extend and improve patients’ lives. 

About Pfizer: Breakthroughs That Change Patients’ Lives 
Pfizer Oncology is at the forefront of a new era in cancer care. Our industry-leading portfolio and pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. Driven by science, we are committed to accelerating breakthroughs to extend and improve the lives of people living with some of the world’s most common cancers.  

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com.